Pfizer Alzheimer’s Disease Drug Fails In Study – 1789th Edition

A promising Alzheimer’s disease drug Pfizer Inc. and a partner are developing failed to work in a late-stage study, a startling disappointment after the potential blockbuster kept symptoms from worsening for a year in a prior test.

Tags: ,

Leave a Reply